181 related articles for article (PubMed ID: 19582723)
1. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.
Patwa TH; Li C; Poisson LM; Kim HY; Pal M; Ghosh D; Simeone DM; Lubman DM
Electrophoresis; 2009 Jun; 30(12):2215-26. PubMed ID: 19582723
[TBL] [Abstract][Full Text] [Related]
2. The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.
Li C; Kim HY; Vuong H; Patwa T; Pal M; Brand RE; Simeone DM; Lubman DM
Cancer Biomark; 2010; 7(1):25-37. PubMed ID: 21045262
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection of autoantibodies on protein microarrays using a modified protein digestion technique.
Patwa TH; Wang Y; Simeone DM; Lubman DM
J Proteome Res; 2008 Jun; 7(6):2553-61. PubMed ID: 18452326
[TBL] [Abstract][Full Text] [Related]
4. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
5. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
Madoz-Gúrpide J; Kuick R; Wang H; Misek DE; Hanash SM
Mol Cell Proteomics; 2008 Feb; 7(2):268-81. PubMed ID: 17916591
[TBL] [Abstract][Full Text] [Related]
6. Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach.
Ghassem-Zadeh S; Hufnagel K; Bauer A; Frossard JL; Yoshida M; Kutsumi H; Acha-Orbea H; Neulinger-Muñoz M; Vey J; Eckert C; Strobel O; Hoheisel JD; Felix K
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244327
[TBL] [Abstract][Full Text] [Related]
7. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.
Anderson KS; Sibani S; Wallstrom G; Qiu J; Mendoza EA; Raphael J; Hainsworth E; Montor WR; Wong J; Park JG; Lokko N; Logvinenko T; Ramachandran N; Godwin AK; Marks J; Engstrom P; Labaer J
J Proteome Res; 2011 Jan; 10(1):85-96. PubMed ID: 20977275
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.
Karabudak AA; Hafner J; Shetty V; Chen S; Secord AA; Morse MA; Philip R
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1757-70. PubMed ID: 23999876
[TBL] [Abstract][Full Text] [Related]
9. Seromic profiling of ovarian and pancreatic cancer.
Gnjatic S; Ritter E; Büchler MW; Giese NA; Brors B; Frei C; Murray A; Halama N; Zörnig I; Chen YT; Andrews C; Ritter G; Old LJ; Odunsi K; Jäger D
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5088-93. PubMed ID: 20194765
[TBL] [Abstract][Full Text] [Related]
10. Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum.
Kilic A; Schuchert MJ; Luketich JD; Landreneau RJ; Lokshin AE; Bigbee WL; El-Hefnawy T
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):199-204. PubMed ID: 18603076
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
[TBL] [Abstract][Full Text] [Related]
13. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
[TBL] [Abstract][Full Text] [Related]
14. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
[TBL] [Abstract][Full Text] [Related]
16. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens.
Qiu J; Madoz-Gurpide J; Misek DE; Kuick R; Brenner DE; Michailidis G; Haab BB; Omenn GS; Hanash S
J Proteome Res; 2004; 3(2):261-7. PubMed ID: 15113102
[TBL] [Abstract][Full Text] [Related]
17. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
18. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.
Babel I; Barderas R; Diaz-Uriarte R; Moreno V; Suarez A; Fernandez-Aceñero MJ; Salazar R; Capellá G; Casal JI
Mol Cell Proteomics; 2011 Mar; 10(3):M110.001784. PubMed ID: 21228115
[TBL] [Abstract][Full Text] [Related]
19. Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma.
Lee MJ; Na K; Jeong SK; Lim JS; Kim SA; Lee MJ; Song SY; Kim H; Hancock WS; Paik YK
J Proteome Res; 2014 Nov; 13(11):4878-88. PubMed ID: 25057901
[TBL] [Abstract][Full Text] [Related]
20. Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays.
Gupta S; Manubhai KP; Mukherjee S; Srivastava S
Methods Mol Biol; 2017; 1619():303-315. PubMed ID: 28674893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
